Intrahippocampal Norleucine¹-Angiotensin IV mitigates scopolamine-induced spatial working memory deficits

Peptides. 2010 Dec;31(12):2209-15. doi: 10.1016/j.peptides.2010.08.023. Epub 2010 Sep 9.

Abstract

Depletion of cholinergic neurons in the hippocampus has been implicated in memory impairment and Alzheimer's Disease (AD). The brain angiotensin AT₄ receptor is co-localized with cholinergic neurons, and the AT₄ receptor has also been implicated in cognitive processing. The current investigation used the spatial win-shift version of the radial arm maze to determine the involvement of AT₄ receptors in spatial working memory formation. We initially established that intrahippocampal scopolamine significantly impaired the spatial working memory performance of Sprague-Dawley rats in the radial arm maze. We also demonstrated that subsequent intrahippocampal infusions of Norleucine¹-Angiotensin IV (Nle¹-AngIV) significantly prevented the scopolamine-induced deficit. Consistent with previously published data on long-term spatial memory, our findings suggest that activation of AT₄ receptors can compensate for impaired spatial working memory resulting from compromised muscarinic acetylcholine receptor function. We further demonstrate that the hippocampus is a site of action for Nle¹-AngIV-mediated cognitive improvement.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / analogs & derivatives*
  • Angiotensin II / pharmacology
  • Angiotensin II / therapeutic use
  • Animals
  • Hippocampus / drug effects*
  • Male
  • Memory Disorders / chemically induced*
  • Memory Disorders / drug therapy*
  • Norleucine / chemistry*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Angiotensin / metabolism
  • Scopolamine / toxicity*

Substances

  • AT4 receptor
  • Receptors, Angiotensin
  • Angiotensin II
  • angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-
  • Norleucine
  • Scopolamine